Description
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Product Unit Size | Cost | Quantity | Stock |
---|
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Cas No. | 9002-10-2 |
---|---|
Purity | ≥95% |
Formula | C42H66N10O16S2 |
Formula Wt. | 1031.2 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Guillaume B, Stroobant V, Bousquet-Dubouch MP, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol. 2012 Oct 1;189(7):3538-47. PMID: 22925930.
Mitchell MS, Darrah D, Yeung D, et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15;20(4):1075-86. PMID: 11844833.
MAO-A/B inhibitor.
CHK1 inhibitor.
Endogenous sphingolipid involved in cell signal...
Podophyllotoxin derivative; topoisomerase II in...
Primarily targets HDAC1
Triterpene saponin found in species of Panax; Î...
CRM1/XPO1 inhibitor.
ROCK inhibitor.
Endogenous opioid peptide; μOR agonist.
mTORC1 inhibitor.
Cannabinoid receptor 2 selective agonist.
ITC precursor found in cruciferous vegetables.<...
Synthesis intermediate
Endogenous cardiomodulatory peptide; NPR-B agon...
JAK2 inhibitor.
Glucose metabolism inhibitor, N-linked glycosyl...
AT1 inhibitor.
Antimicrobial peptide found in Vespula lewisii,...
Statin; HMG-CoA reductase inhibitor.
Nicotinamide analog prodrug; fatty acid synthet...